Evgen Pharma PLC
LSE:EVG
Evgen Pharma PLC
LSE:EVG
Price:
0.8
GBX
Market Closed
Market Cap:
£3.4m
Income Statement
Earnings Waterfall
Evgen Pharma PLC
Evgen Pharma PLC
Income Statement
Evgen Pharma PLC
Evgen Pharma PLC
Currency: GBP
| Mar-2016 | Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+90%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(1)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(5)
|
(6)
|
(5)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Other Operating Expenses |
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(2)
|
(3)
|
(3)
|
(5)
|
(5)
|
|
| Operating Income |
(2)
N/A
|
(3)
-68%
|
(4)
-24%
|
(4)
+0%
|
(3)
+17%
|
(3)
-4%
|
(3)
+0%
|
(3)
+6%
|
(3)
-8%
|
(3)
-8%
|
(3)
+6%
|
(3)
+10%
|
(4)
-29%
|
(3)
+14%
|
(5)
-48%
|
(5)
-8%
|
(4)
+15%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(4)
-15%
|
(4)
+2%
|
(4)
+0%
|
(3)
+17%
|
(3)
-4%
|
(3)
+0%
|
(3)
+6%
|
(3)
-8%
|
(3)
-7%
|
(3)
+5%
|
(3)
+10%
|
(4)
-28%
|
(3)
+15%
|
(5)
-47%
|
(5)
-7%
|
(4)
+15%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
|
| Income from Continuing Operations |
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
|
| Net Income (Common) |
(3)
N/A
|
(4)
-16%
|
(3)
+15%
|
(3)
+0%
|
(3)
+16%
|
(3)
-4%
|
(3)
+3%
|
(2)
+7%
|
(3)
-11%
|
(3)
-9%
|
(3)
+9%
|
(2)
+12%
|
(3)
-26%
|
(3)
+8%
|
(3)
-23%
|
(4)
-21%
|
(3)
+17%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.05
+17%
|
-0.04
+20%
|
-0.04
N/A
|
-0.03
+25%
|
-0.03
N/A
|
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
